Monash IVF Group Ltd (ASX:MVF) is one of Australia’s leading providers of assisted reproductive services, operating fertility clinics across Australia and internationally. The company plays a key role in the healthcare sector, particularly in fertility treatment and reproductive medicine.
4DMedical (ASX:4DX) shares traded at AUD 5.790, down AUD 0.049 or 0.856%, on 20 April 2026, on volume of 6,559,404 shares. The bid-offer spread at the time of capture was AUD 5.780 to AUD 5.790 and market capitalisation was AUD 3.44 billion. The marginal …
The S&P/ASX 200 Health Care Index itself was narrowly higher, up 0.02 per cent at 28,094.00 points. The Ramsay share price move reflects both defensive sector flows and ongoing news flow around private hospital funding agreements between operators and private health insurers in Australia.
The Sigma share price performance reflects the unique position SIG now holds in Australian pharmacy: a combined wholesaling, franchising and owner-operator ecosystem spanning community pharmacy, consumer health, and private-label products. With the integration underway and regulatory proceedings well behind the combined entity, investors are …
Telix is in focus thanks to its commercial-stage radiopharmaceutical business, anchored by the prostate cancer imaging agent Illuccix and an extensive pipeline of next-generation targeted radionuclide therapies across prostate, renal and glioblastoma indications. The company has become a notable global radiopharmaceutical operator with operations …
Neuren Pharmaceuticals Limited (ASX: NEU) slipped 0.96 per cent to $12.36 on 17 April 2026, placing the clinical-stage biopharmaceutical company among the notable decliners on the S&P/ASX 200 Health Care Index at the open. While the broader XHJ index crept higher by 0.02 per …
Mesoblast Limited (ASX: MSB) was unchanged at $2.24 on 17 April 2026 in early ASX trade, with the stock appearing at the bottom of the S&P/ASX 200 Health Care Index top movers list for the session with a flat intraday change. The broader XHJ …
Cochlear Limited (ASX: COH) slipped 0.38 per cent to $169.15 on 17 April 2026 in early ASX trade, making the global hearing implant leader one of the modest decliners in the S&P/ASX 200 Health Care Index on the day. The broader XHJ index was …
Ansell Limited (ASX: ANN) eased 0.18 per cent to $27.67 on 17 April 2026, little changed on a day when the broader S&P/ASX 200 Health Care Index inched up 0.02 per cent to 28,094.00 points. Ansell's movement was modest and consistent with normal trading …
Proteomics International Laboratories Ltd (ASX:PIQ) has announced a series of organisational and leadership changes as part of an ongoing strategic review aimed at repositioning the company toward a commercially focused diagnostics model. The update reflects a structural shift in operations, as the company moves …